- Data-driven disease insights
We collaborate with the world’s leading pharma, biotech and academic organisations to lower the risks and time frames in disease research and preclinical drug discovery.
Euretos provides a unique combination of predictive computational disease models and direct access to our AI-integrated knowledge base of biomolecular databases, literature and patents to evaluate predictions and findings. This empowers scientists to draw their own, evidence-based, conclusions and develop data-driven insights into human disease biology.
Our ready-to-use applications and capabilities enable taking a data-driven approach to:
• Target Discovery - Novel target predictions to improve preclinical pipeline performance in all therapeutic areas
• Indication Selection - Novel disease association predictions to expand indications of existing drugs
• Target Evaluation - Accelerate assessment of target candidates from in-house discovery and in-licensing
Work with Euretos to:
• Get novel target and indication predictions to develop your in-house and in-licensing pipeline
• Empower your researchers to evaluate which assets to move forward in preclinical testing
• Gain collaborative insights by working with our translational science team
• Lower time frames and risks by leveraging proven experience and ready-to-use applications